The Pennant Group (NASDAQ:PNTG – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.900-0.960 for the period, compared to the consensus EPS estimate of 0.910. The company issued revenue guidance of $665.3 million-$706.5 million, compared to the consensus revenue estimate of $679.3 million.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on PNTG. Stephens reissued an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a report on Wednesday, October 9th. Oppenheimer boosted their target price on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research report on Friday. Royal Bank of Canada raised their price target on The Pennant Group from $26.00 to $38.00 and gave the company an “outperform” rating in a report on Wednesday, October 23rd. Finally, Truist Financial lifted their price target on The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Monday, October 7th.
Get Our Latest Report on The Pennant Group
The Pennant Group Price Performance
The Pennant Group (NASDAQ:PNTG – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. The Pennant Group had a return on equity of 14.02% and a net margin of 3.24%. The business had revenue of $168.75 million for the quarter, compared to analysts’ expectations of $156.71 million. As a group, sell-side analysts anticipate that The Pennant Group will post 0.75 EPS for the current year.
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Further Reading
- Five stocks we like better than The Pennant Group
- Top Stocks Investing in 5G Technology
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- How to Use the MarketBeat Dividend Calculator
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Overbought Stocks Explained: Should You Trade Them?
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.